Episode 18. Management of Smoldering Multiple Myeloma

Blood Cancer Talks

Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।

1+ y ago 46:32

MP3•एपिसोड होम

1. How I Approach Smoldering Myeloma (Vaxman and Gertz):

https://ashpublications.org/blood/article/140/8/828/485274

2. Risk-Stratification Models in SMM:

Mayo 2018 model: https://pubmed.ncbi.nlm.nih.gov/29895887/

PETHEMA (Spanish) model: https://pubmed.ncbi.nlm.nih.gov/17576818/

PANGEA model: https://pubmed.ncbi.nlm.nih.gov/36858677/

IMWG SMM model: https://pubmed.ncbi.nlm.nih.gov/33067414/

3. QuiRedex RCT (Lenalidomide-Dexamethasone vs Observation in High-Risk SMM):

https://pubmed.ncbi.nlm.nih.gov/36067617/

4. ECOG E3A06 RCT (Lenalidomide vs Observation in SMM):

https://pubmed.ncbi.nlm.nih.gov/31652094/

5. Intensive Treatment in High-Risk Smoldering Multiple Myeloma:

GEM-CESAR: https://ashpublications.org/blood/article/140/Supplement%201/292/490268

ASCENT: https://ashpublications.org/blood/article/140/Supplement%201/1830/492739

6. Current Clinical Trial Landscape in Smoldering Myeloma:

https://pubmed.ncbi.nlm.nih.gov/34114943/

7. How Light Chain Proteinuria Modulates Risk of Progression in Patients with sFLC ratio>100 as the only Myeloma-Defining Event?

https://pubmed.ncbi.nlm.nih.gov/35190659/

52 एपिसोडस

#Fitness #Medicine #Rajshekhar Chakraborty and Ashwin Kishtagari #Ashwin Kishtagari #Rajshekhar Chakraborty #Hematology #Cancer #Podcasting Education #Edward Cliff